Clinical trial
Impact of the Pulmonary Index of Microcirculatory Resistance in Pulmonary Arterial Hypertension
NCT05812976 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of the Pulmonary Index of Microcirculatory Resistance in Pulmonary Arterial Hypertension
- Lead sponsor
- University of California, Los Angeles
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 1, 2023
- Completion date
- April 8, 2025
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pulmonary hypertension